Urinalysis cleveland

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 has issued a Special Notice of Intent to Sole Source for a urinalysis system at the Louis Stokes Cleveland Veterans Affairs Medical Center. The notice involves a Request for Quote (RFQ 36C25025Q0940) and justification for procuring a Beckman Coulter DxU Iris Workcell Automated Urinalysis System under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing). The agency intends to award a five-year, firm fixed-price delivery order against an existing Federal Supply Schedule contract specifically to Beckman Coulter. The procurement is classified under PSC 6640 (Laboratory Equipment and Supplies) and is valued under the Simplified Acquisition Threshold. The notice was posted on September 11, 2025, with a response deadline of September 17, 2025.

The purpose of this Special Notice is to procure a comprehensive, fully integrated urinalysis testing system that combines automated urine chemistry and digital microscopy capabilities into a single workcell platform. The system must perform 12 urine chemistries, identify multiple microscopic particles, process over 200 samples per hour with 50-specimen walk-away capability, and interface with the VA Vista system while reducing manual sample review to less than 3-4% and meeting CLIA and CLSI standards. Interested parties may submit capability information by September 17, 2025, at 5 PM EST via email to rachelle.hamer@va.gov with the specified subject line. The procurement is unrestricted with no set-aside designation, though it emphasizes participation from service-disabled veteran-owned and veteran-owned small businesses. The VA has determined through market research that Beckman Coulter is the sole manufacturer capable of meeting their unique operational and clinical requirements for this integrated platform solution. The contract will include equipment, installation, reagents, consumables, maintenance, training, and support services on a "reagent rental" or "cost-per-reportable test" basis with a base period from October 1, 2025, through September 30, 2026, and four one-year option periods.